Abstract
Background Sexual violence (SV) is an important public health problem which may cause long-lasting health problems. SV in older adults remains neglected in research, policies and practices. Valid SV prevalence estimates and associated risk factors in older adults are currently unavailable.
Objective To measure lifetime and past 12-months sexual victimisation in older adults living in Belgium, its correlates, assailant characteristics and the way that victims framed their SV experiences.
Design Cross-sectional general population study.
Setting Community-dwelling, assisted living and nursing homes.
Participants 513 people of 70 years and older living in Belgium.
Methods SV was measured using behaviourally specific questions based on a broad definition of SV. Participants were selected via a cluster random probability sampling with a random route finding approach. Information on sexual victimisation, correlates, assailant characteristics and framing was collected via structured face-to-face interviews.
Results Lifetime SV prevalence was 44% (55% F, 29% M). Past 12-months prevalence was 8% (9% F, 8% M). Female sex and a higher number of sexual partners were associated with lifetime SV (p <.05), non-heterosexual sexual orientation with past 12-months SV (p <.05). Correlates generally linked to elder abuse and neglect were not linked with SV. ‘Someone unknown’ was identified as most common assailant.
Conclusions SV appears to be common in older adults in Belgium. Both correlates and assailant characteristics seem to differ from previous studies on elder abuse and neglect. Recognising older adults as a risk group for sexual victimisation in research, policies and practices is of the utmost importance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was predominantly supported by the Belgian Federal Science Policy Belgian Research Action through the Interdisciplinary Networks funding scheme, grant number BR/175/A5/UN-MENAMAIS. CVʹs contribution was supported in part by the Research Foundation Flanders (FWO) Postdoctoral Fellowship funding scheme, grant numbers 12C0616N, 12C0619N.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical committee of Ghent University/University Hospital (Belgian registration number B670201837542)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Declaration of interest: None.
Data Availability
The data that support the findings of this study are available from the corresponding author, A.N., upon reasonable request.
